Skip to main content
. 2009 Oct 15;12(1):2–6. doi: 10.1093/neuonc/nop002

Fig. 1.

Fig. 1.

The prognostic advantage conferred by deletion of chromosomes 1p–19q on PFS is lost in patients with combined chromosome 9p loss.